Howard L. Kaufman, MD

Articles by Howard L. Kaufman, MD

Avelumab Produces Durable Responses in Metastatic Merkel Cell Carcinoma

Published: June 22nd 2016 | Updated: April 27th 2023

In this video we discuss promising results of the anti–PD-L1 agent avelumab in patients with metastatic Merkel cell carcinoma who had previously been treated with chemotherapy.

Latest Updated Articles

Avelumab Produces Durable Responses in Metastatic Merkel Cell Carcinoma
Published: June 22nd 2016 | Updated: April 27th 2023

Howard L. Kaufman, MD

Articles by Howard L. Kaufman, MD

Avelumab Produces Durable Responses in Metastatic Merkel Cell Carcinoma

Latest Updated Articles

Trending on CancerNetwork

Nivolumab/Chemo Yields Long-Term Survival in Advanced Gastric Cancers

FDA Grants Traditional Approval to Encorafenib in BRAF-Mutated CRC

FDA Grants Fast Track Designation to ART6043/Olaparib in BRCA-Mutated, HER2– Breast Cancer

FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma

FDA Issues Partial Clinical Hold on Lorigerlimab Trial in Gynecologic Cancers